According to the company, Elzofri is the first patented long-acting injectable paliperidone palmitate developed in China and approved by the FDA for the treatment of schizophrenia and schizoaffective disorder.
According to the company, Elzofri is the first patented long-acting injectable paliperidone palmitate developed in China and approved by the FDA for the treatment of schizophrenia and schizoaffective disorder.
Sign in to your account